Arkolith/Insider Trading/MEIP/Form 4/A

Flynn James P

DirectorMEI Pharma, Inc. (MEIP) · full profile →Form 4/A · filed Jan 12, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 18, 2023Grant(A)10K—$010K
Dec 18, 2023Grant(A)7K—$07K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0000950170-24-004228) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML